Table 1.
Tumor characteristics and patient demographics.
| Age (years) | 71 (38–85) |
|---|---|
| Sex | |
| Male | 22 (59%) |
| Female | 15 (40%) |
| Histology | |
| Papillary predominant | 19 (51%) |
| Acinar predominant | 3 (8%) |
| Lepidic predominant | 6 (16%) |
| Solid predominant | 9 (24%) |
| Pathological T factor | |
| pT1a | 4 (11%) |
| pT1b | 12 (32%) |
| pT1c | 13 (35%) |
| pT2a | 6 (16%) |
| pT2b | 0 (0%) |
| pT3 | 2 (5%) |
| Nodule consistency | |
| Part-solid nodule | 15 (40%) |
| Solid nodule | 22 (59%) |
| Total size of all nodules (mm) (n = 37) | 25.7 (10.0–60.0) |
| Total size of part-solid nodule (mm) (n = 15) | 28.1 (15.0–42.0) |
| Solid portion size of part-solid nodule (mm) (n = 15) | 15.7 (5.0–35.0) |
| Total size of solid nodule (mm) (n = 22) | 24.1 (10.0–60.0) |
| Volume of all nodules (mm3) (n = 37) | 5457.9 (122.5–99,590.3) |
| Volume of part-solid nodule (mm3) (n = 15) | 1510.9 (122.5–4105.6) |
| Volume of solid nodule (mm3) (n = 22) | 8149.0 (398.1–99,590.3) |
| PD-L1 expression | |
| Positive (TPS ≥ 50%) | 11 (30%) |
| Low or negative (TPS < 50%) | 26 (70%) |
Age, tumor size, and nodule volume are shown as median (interquartile range).